In compliance with Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) (Amendments) Regulations 2018, please find attached herewith disclosure on Related Party Transactions, on consolidated basis in the format specified in accordance with applicable accounting standards for the half year ended on March 31, 2022.

Dear Sir/Ma'am, In reference to above cited subject & pursuant to Regulation 23 (9) of Securities & Exchange Board of India (Listing Obligations & Disclosures Requirement) Regulations, 2015, please find herewith enclosed disclosure of Related Party Transactions for the half year ended 31st March 2022. We request you to kindly ignore our earlier announcement dated 13.06.2022 w.r.t. Related Party Transactions.

Analyst / investor meet intimation

R J Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/06/2022 ,inter alia, to consider and approve R J Bio-Tech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/06/2022, inter alia, to consider and approve the appointment of additional directors (non-executive & non-independent)

Intimation of loss of share certificates

Consequent upon successful commissioning, second part capacity of 15 MW out of 56 MW Kawas Solar PV Project at Kawas, Gujarat, is declared on Commercial Operation w.e.f. 00:00 Hrs. of 15.06.2022. With this, standalone installed and commercial capacity of NTPC will become 54666.68 MW, while group installed and commercial capacity of NTPC will become 69031.68 MW.

This is to inform that the Company has allotted 1,76,434 equity shares on June 13, 2022, pursuant to the exercise of Restricted Stock Units by eligible employees as hereunder: 10,287 equity shares under the 2015 Stock Incentive Compensation Plan; 1,66,147 equity shares under the Infosys Expanded Stock Ownership Program 2019. Consequently, on June 13, 2022, the issued and subscribed share capital of the Company stands increased to ? 21,038,103,595/- divided into 4,207,620,719 equity shares of ?5/- each. This is for your information and records.

With respect to captioned subject, please find enclosed copy of newspaper publication published in Financial Express (English edition) and Business Remedies (Hindi edition) on 14th June, 2022. This is for your information and record.

14.06.2022 Department of Corporate Services Bombay Stock Exchange Limited Phiroze Jee Jee Bhoy Towers Dalal Street Mumbai - 400 001 Dear Sir, Scrip Code : BSE: 517238 Sub: Intimation as per Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Issue of Duplicate share certificate - Folio No. 26345 Please find enclosed the intimation letter dated 14th June 2022, received from our RTA - M/s. Integrated Registry Management Services Private Limited, Chennai-600017, providing information regarding issue of duplicate share certificates to the shareholders of the Company. This information is being submitted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record. Kindly take the same on your records. Thanking You, Yours faithfully, for DYNAVISION LIMITED M.S.MEERAMOHIDEEN DIRECTOR

Please find enclosed herewith disclosures of related party transactions on consolidated basis, as prescribed under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November 2021, for the half year ended 31st March, 2022.